CRP and myasthenia gravis: Compared with MG rats, both FA and OZ treatment significantly reduced TNF-α level (Fig. 7C), and only OZ administration markedly decreased serum CRP and IL-6 levels and increased adiponectin level (P<0.05, Fig. 7A and E).